BAY 80-6946 211 C2H2O4/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20

C2H2O4/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20

Azimilide has been studied for its anti-arrhythmic effects: its converts and maintains sinus rhythm in patients with atrial arrhythmias

PubMed Central PMCID: PMC2702280

Solubility: DMSO : 50 mg/mL (147

7 macrophages[1]

BAY 80-6946 211 C2H2O4/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20Copanlisib also known as BAY 80 6946, is a potent phosphoinositide 3 kinase (PI3K) inhibitor. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.